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ABSTRACT
DNA interstrand cross-linking agents have been recognized for many years to be
powerful antirumof chemotherapeutics. While the interactions between free DNA and many
anticancer drugs have been explored extensively, there is less infonnation available about these
interactions with nucleosomal DNA. Nitrogen mustards have been reported to exhibit relatively
similar cross-linking sites and efficiencies of binding in free and nucleosomal DNA, but
mitomycin C exhibits markedly reduced cross-linking near the center of nucleosomal DNA. This
current study focuses on cisplatin interstrand cross-linking of the 154 base pair 55 rRNA gene
fragmem of Xenopus borealis reconstituted with histones from chicken erythrocytes. The results
showed that nucleosomal structure positively affects the efficiency of interstrand cross-linking of
DNA by cisplatin at one site on the gene, believed to be at a site three-helical turns from the
dyad. Nevertheless. nuc1eosomal structure does not determine the sites at which cisplatin can
bind to DNA. The similarity in cross-linking pauems between free and nucJeosomal DNA
supports a locally dynamic model of the nucleosome. Additional reconstitution experiments also
demonstrate that a cisplatin-modified DNA molecule cannot be precisely incorporated imo a
nucleosome, indicating that cross-linking of the DNA molecule somehow impedes adoption of
nucleosomal structure.
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INTRODUCTION
DNA cross-linking agents have a wide variety of effects on cells. While the nitrogen
mustards, milOmycin C, and cisplatin are known antitumor agents, other cross-linkers such as
some of the diepoxides are carcinogens (Hopkins et al., 1991; Ehrenberg and Hussain. 1981).
The mechanisms by which these agents have such opposite effects is still largely unclear.
However. the structure of the cross-link and the resulting distortion in DNA structure that cross
linking induces are believed to play key roles in cytOloxic and carcinogenic properties. The in
vitro aspects of interactions between DNA and cross-linkers have been well studied, but a large

portion of the DNA in the cell is complexed with histone proteins in order to form chromatin.
The incorporation of DNA into chromatin alters the dynamic and structural propenies of the
DNA and, thus, may influence reactivity and repair of the DNA (Millard, 1996). Studies
incorporating nucJeosomal structure might, therefore, provide further insight into the
carcinogenicity and cylolOxicity of cross-linkers. Relatively few studies have been done, but
most have found that nucleosomal structure has little impact on site preference of cross-linking
with some effect on efficiency of interstrand cross-linking at panicular sites (Millard

el

aI.,

1998). The focus of this study was to investigate the impact of nucleosomal structure on
interstrand cross-linking of DNA by cisplatin. In order to more closely mimic in vivo conditions,
we made use of the 154 base pair (bp) EcoRl/Rsal restriction fragment of the 5S rRNA gene of
Xenopus borealis reconstituted with core panicles isolated from chicken erythrocytes.

The antitumor activity of cis-diamminedichloroplatinum (II), also called cisplatin, was
discovered in 1969 (Rosenberg et ai., 1969), and the Food & Drug

Administration~approvedit

for use in clinical treatments of testicular cancer, ovarian cancer, and cancers of the head and
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neck in 1979 (Borman. 1995). Cisplatin consists of a centrally oriented platinum bound to two
chlorides and two amino groups in a cis conformation (Figure 1).
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Figure 1. The structure of cis-diamminedichloroplatinum (II).
In an aqueous environment. the molecule loses the chlorides and fonus an aqua species which
can then react with nucleophilic groups on nucleic acids (Chu, 1994). Cisplatin first covalently
binds to the N-7 position on a purine (guanine is preferred) to fonu a monoadduct (Figure 2).
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Figure 2. The site of cisplatin bincting at the N-7 position on guanine.
This monoadduct can then (1) react with an external nucleophile such as the solvent or a protein.
(2) react with a second purine on the same strand 10 form an intrastrand cross-link, or (3) react

with a second guanine on the opposite strand to form an inrers1rand cross-link at 5'GC sequences
(Figure 3) (Hopkins er a!., 1991).
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Figure 3. The structure of clifferent types of cisplatin adducts. The solid lines
represent complementary strands of DNA and the dashed lines represent the
cross-linking agent. a) monoadduct; b) intrasttand cross-link; c) interstrand cross
link occurring at S'GC sequences
About 90% of the original monoadducts result in 1,2- intrastrand cross-links (Eastman, 1986).
While interstrand cross-links are the minor product, making up less than 5% of the original
monoadducts, it is still debated as to which type of cross-links are the most biologicaJly relevant
(Malinge and Leng, 1999).
The cisplatin interstrand cross-link has very severe effects on the structure of the helix.
Cisplatin interstrand cross-links cause the helix to 10caJly switch from the right-handed helical
form to the left-handed helical form (Huang et al .. 1995; Kasparkova et al., 1996). In addition,
0

the interstrand cross-links unwind the helix about 79 and bend the axis of the phosphodiester
backbone 49· toward the minor groove (Malinge and Leng, 1999). The cywsine residues, no
longer paired with the guanines, are extruded from the double hehx allowing the 180· fOUl.tion of
the platinated guanine that brings the structure into the minor groove. The resulting eleclrOstatic
interactions between the oxygens of the phosphate groups on the platinated guanine residues and
the square planar Pt(ll) atom lead to a pseudo-octahedral geometry around the metal ion. This
interaction and the stacking of both platinated guanines with the adjacent base pairs contributes
to the stabilization of the structure (MaJinge and Leng, 1999). Since these resulting distortions
are believed to be linked to the drug's cytotoxicity, the question then follows: does the
incorporation of DNA into chromatin affect the ability of cisplatin to cross-link the DNA? In
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order to investigate this question, we developed a more biologically relevant model. The model
includes the 154 bp EcoRlJRsal restriction fragment of the 55 rRNA gene of Xenopus borealis
that is reconstituted with histones isolated from chicken erythrocytes.
The 154 bp restriction fragment (Figure 4) of the 55 rRNA gene of Xenopus borealis was
chosen because it has been previously shown

to

exhibit exceptional nucleosomal positioning

properties (Hayes et af., 1990).
1.

8

25

12

5' AAITCGAGCT

C!i.C.CCGGGGA

!;CCCCCCCAG

AAG!Z.!;A!Z.!;AC

44

68

75

30

TCCGGJ;rGGG

47

79

AAAGTCA!iC.C

ITGT.G.C.TC.G.C.

ACCACCCTGA

AAGT!i.C.CCGA

AAGGGGAGGA
86

CTACG.G.C.CAT

lOS

129

TCTCGGAA!iC.

134

CAA!i.C.AGGGT

TATCGTCTGA
144

CGG.G.C.CTGGT

151

TAGT-3'

Figure 4. The sequence of the 154 bp EcoRl/Rsal restriction fragment of the 55
rRNA gene of Xenopus borealis used in this study. Numbering is from 1 to 154 in
the 5'-3' direction. The fourteen d(GC) sites for potential interstrand cross-linking
are underlined, balded, and numbered with the 5'residue.

Nucleosomal structure consists of repeating subunits called nucleosomes. Nucleosomes include
165-246 bp of DNA compJexed through ionic interactions with histone proteins (van Holde,
1989). The nucleosome can be divided into two regions, the core panicle and the linker region.
The core panicle consists of 146 bp of DNA wrapped one and three-quarters times around a
histone octamer containing two copies of H2A, H2B, H3, and H4 proteins (Kornberg and Klug,
1991). Within this strucrure, the octamer is composed of two dimers of the H2A and IDB
histones and a tetramer of the H3 and H4 histones. The linker region is 20-70 bp of DNA in
length, and it contains binding sites for histone proteins HI and H5 (in avian erythrocytes) as

5

well as other non-histone proteins (van Holde, 1989). The incorporation of DNA into the above
structure of proteins has several structural implications, including a curvature of about 4Y per
helical rum and various bends, which result in periodic narrowing and widening of the minor
groove (Millard, 1996).
The 14 putative binding sites of cisplatin interstrand cross-linking in the 154-mer, given
the 5'GC sequence preference, are presented in a variety of rotational and translational
conformations when the 154-mer is incorporated into the nucleosomal core particle. The
rOtational positioning refers to the orientation of the site with respect to the histone core (i.e.
facing toward or away from the histone molecules). The translational positioning refers to the
number of base pairs a site is located from the dyad (C76 in this sequence) (pruss and Wolffe,
1993). The periodic compression and expansion of the minor and major grooves giving rise to
varying distances between the guanine N-7 atoms, the distortion of the DNA molecule by the
core particle, and the site concealment by DNA-protein contacts could all be sources of potential
differential site specificity between free and nucleosomal DNA for cisplatin interslrand cross
linking.
Previous work on interstrand cross-linking of DNA by cisplatin using nucleosomal calf
thymus DNA has shown that reactivity varies depending on the level of binding. At higher R r
values of 0.1-0.2 (moles of drug/moles of nucleotide base pairs), the binding sites in free DNA,
chromatin, and nucleosomal DNA show similar reactivity, suggesting no preference for any
particular region (Roussier et ai., 1983). However, at lower levels of platinum (R r < 0.03) the
amount of bound platinum is reduced for core panicles relative to chromatin and free DNA,
indicating preferential binding to linker DNA (Foka and Paoletti, 1986). Moreover, it was found
that micrococcal nuclease digestion of chromatin was inhibited at R f < 0.05. NonnaJly, when
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micrococcal nuclease is incubated with chromatin, the result is rapid cleavage of linker DNA to
produce polynucleosomes and ultimately core particles (Noll, 1974). Thus, inhibition of
micrococcal nuclease digestion of chromatin by cisplatin at these low R f values is also suggestive
that cisplatin binds preferentially to linker DNA at such R f values (Millard, 1996). The
preference of cisplatin for linker DNA is attributed to histone-induced constraint on the core
particle (Millard, 1996). We wished to further investigate the effects of nucleosomal structure on
cisplatin by narrowing our focus to look specifically at interstrand cross-linking of cisplatin
within the model described above to determine whether similar tendencies in cross-linking
existed.
Interestingly, the sterioisomer of cisplatin. trans-diamminedichloroplatinum (II)
(lfansplatin). is a clinically inactive compound that has little ro no antitumor activity (paquet el

ai .. 1999), but there has recently been some controversy over this point (Malinge and Leng,
1999). Due

[0

the vastly different effects seen from a slight change in structure of the drug, we

thought that a parallel study of transplatin in conjunction with cisplatin might provide some
adclitional insight into the mechanisms relating to cisplatin's cytotoxicity. Thus, we also
investigated the effect of nucleosomal structure on the interstrand cross-linking of DNA by
transplatin.
Similar to cisplatin, transplatin does bind to the N-7 position of guanine to form a
monoadducl. However, unlike cisplatin. transplatin cannot form 1,2- intrastrand cross-links
because of steric hindrances and instead forms interstrand cross-links with a cytosine on the
opposite strand, along with some 1,3- intrastrand cross-links with a second guanine. The 1,3
adducts have been shown, however, to frequently rearrange

to

fonn the interstrand cross-links

(paquet el al., 1999). In addition, transplatin has a much higher reactivity with glutathione, thUS,

7

potentially leading to a lower level of interstrand cross-links (Malinge and Leng, 1999). The
kinetics of the reactions of the two isomers are very different with the transplatin reactions being
much slower (paquet et al., 1999). In addition, the distortions in the DNA induced by transplatin
are much less severe than those induced by cisplatin. The helix is unwound by only about 12

0

0

and the axis of the phosphate-sugar backbone is bent 26 toward the minor groove (Malinge and
Leng, 1999). Since these differences might be linked to the inability of transplatin to be used as
an effective antitumor agent, the effects of nucleosomal structure on both cisplatin interstrand
cross-linking and transplatin interstrand cross-linking of DNA could provide very interesting
information about the mechanisms of cytotoxicity.

8

MATERIALS & METHODS
Purification of Core Particles
Core particles were generously purified by Jake Conklin using a method similar to
Millard. Spencer, and Hopkins (1998), from chicken erythrocytes (Jason's Butcher Shop; Albion,
ME). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was then
performed using an 18% Tris-glycine gel to ensure the purity of the histone samples (Sambrook
et al., 1989). Core particles were quantified on a Shi madzu UV-160 spectrophotometer by their

DNA using the convention that 50 JlglmL DNA is equivalenl to 1 OD at 260 nm (Sambrook et
al.. 1989).

Isolation ofDNA Fragment
pXP-ll (Kuduvalli er al., 1995), containing a portion of the 5S rRNA gene of Xenopus
borealis. was kindly provided by the Tullius laboratory (John Hopkins Uni versity).
Transformations iow Eschericia coli were graciously performed by Jake Conklin, and the
plasmid was further purified from those colonies using Qiagen p-2500 purification columns. For
two 500 mL cultures of 2 colonies. the yield was approximately 8 mg of DNA at 1 IlglJ1L. DNA
was quantified on the Shimadzu UV-160 spectrophotometer using the convention that 50 JlglmL
is equivalent to 1 OD at 260 om (Sambrook ef al., 1989).
For each experiment a varying amount of DNA was required, and thus the numbers of
digestion replicates were varied. Digestions were performed under standard conditions
(Sambrook er al., 1989). For each 400

J1L digestion replicate, 20 Jlg of DNA wen~ digested with

0.06 units/reaction EcoRl and 0.03 units/reaction Rsal in IX Reaction Buffer 1 (from New
England Biolabs; lOX Reaction Buffer 1 diluted in sterile H 20). The reactions were incubated at

9

3TC for at least 2 hr and then ethanol precipitated using 1/10 volume of 3 M sodium acetate
(NaOAc) (pH 5.0) and 2 volumes of chilled 95% ethanol. The mixtures were next incubated at
-20"e for at least 20 minutes and then centrifuged in an Eppendorf model 5402 refrigerated
microcentrifuge at 11,600 x g for 15 minutes at 4"C. The supernatant was removed and
discarded, and the pellets were washed in 1 mL of chilled 80% ethanol. Washes also consisted of
o

an incubation at -20 e for at least 20 minutes and centrifugation in the above manner. The pellet
was dried in a Labconco Centrivap and then 3'-end radiolabeled with

32p

under standard

conditions (Sambrook et ai., 1989). Each labeling reaction consisted of 0.005 units of Klenow
fragment, IX Eco Pol buffer (from New England Biolabs; lOX Eco Pol Buffer), 25 jJ.Ci 32p_
dATP (Amersham) in a total volume of 26 !Jl.. The reactions were incubated at room
temperature for 15 minutes, and then 20 jJ.L of native dye (0.1 % xylene cyanol! 50% glycerol)
were added to each tube.
In order to purify the desired 154-mer, the reactions were run on a 19 cm x 16 cm 6%
native PAGE gel [8 mL 30% acrylamide (37.5: 1 acrylamide:bisacrylamide), 8 mL 5X TBE, 400
jJ.L 20% APS, 20

~

TEMED] in IX TBE at 250 Vat 4°C for - 2 hr or until the dye had

migrated 10 cm. The gel was visualized using autoradiography which consistently revealed two
bands with the I54-mer at a much higher mobility near the dye front (Figure 5).
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Labconco Centrivap, 50 IJL of H 20 was added to each one in order to dissolve the DNA, and the
replicates were then consolidated as necessary. Finally, the 154-mer was re-precipitated in 1 rnL
of 80% ethanol, which was chilled, pel/eted, and dried as above.

Reconstitution
Two methods of reconstitution were employed. For the first method, herein called the
Wolffe method (Hayes et ai., 1991), the dried, radiolabeled 154-mer from above (in a
siliconized, sterilized microcentrifuge tube) was placed in 0.325 OD 26O or 0.975 OD26O of core
panicles and 1 M NaCl (5 J,JL of 4 M NaCI). The final volume was brought up to 20

~

with

100: 1 of TE [10 mM Tris (pH 7.5) and 1 roM EDT A]: phenylmethylsulfonyl fluoride (PMSF)
(50 mM PMSF in isopropanol). The mixture was incubated for 1 hr on ice. The salt
concenrration was then gradually decreased by adding aliquots of TEJPMSF (5

~L

for 1 hr, 5

~

for 1 hr, 170 ilL for 15 minutes, 200 ilL for 15 minutes) (Hayes, et ai., 1991). For the second
method, herein called the Smerdon method (Suquet and Smerdon, 1993), the dried, radiolabeled
l54-mer was mixed with 2.93 OD 260 0r 4.880° 260 of core particles, 1 M NaCI (5

~4

M NaCl),

and the final volume was broughl to 100 ~ with TEJPMSF. The mixture was incubated on ice

for 45 minutes and then transferred to a 0.5 rnL slide-a-Iyzer. The salt concentration was then
gradually decreased by dialyzing the mixture at 4"C for 3 hr periods in 200 mL TEJPMSF
containing 0.8 M NaCl, 0.6 M NaCl, and 0.05 M NaCL The contents of the slide-a-lyzer were
then removed and placed in a microcentrifuge rube. Reconstitutions were stored at 4°C.
Reconstitutions were analyzed and free and reconstituted nueleosomal 15'4-mer were

separated using 6% native PAGE. The gels (19 x 16 em, 8 mL 30% 37.5:1 aery1ami de:
bisacrylarnide, 4 mL 5X TBE, 4 rnL 50% glycerol, 200

Ill- 20% APS,

16 ilL TEMED) were run
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in 0.5X TBE at 4·C for - 3 hr or until the dye front had migrated about 10 em. If samples were to
be reacted with cisplatin or transplatin, separation of reconstituted and free 154-mer by PAGE
was delayed until after the platinum-modification reactions had taken place in order to ensure
that both the free and nucleosomal DNA were subjected to the same reaction conditions.

Cisplatin Cross-linking Reaction
A 1.0 mM cisplatin (Aldrich) stock (3 mg of cisplatin in 10 mL H 20) was prepared 24 hr

before incubation. The stock was diluted 1: 10 with H 20, and thus the appropriate amount of
cisplatin for each reaction was taken from a 0.1 roM cisplatin solution in order to increase the
accuracy of the final solution concentration. Two concentrations of cisplatin were used to cross
link DNA: 0.01 mM and 0.0025 mM. The first set of experiments had final volumes of 150 ilL.
They contained 100 ilL of a Wolffe reconstitution or 40

~

of a Smerdon reconstitution. IX

ptatination buffer [15 ilL of lOX stock containi ng 400 mM sodium perchlorate (NaCIOJ. 20 mM
monobasic potassium phosphate (H2KP0 4 ) (pH 7.6)J, and 0,01 mM cisplatin or 0.0025 mM
cisplatin that was brought up to final volume with H 20. Subsequent experiments were scaled
down to a 90 IlL final volume using 70 ilL of Wolffe reconstitution. This smaller volume was
used so that the entire reaction could be loaded onto one gel lane. All reactions were incubated in
the dark at 37°C for 8 hr. A 10 ~ portion of native dye was then added to each tube. and the free
and reconstituted nucleosomal 154-mer were separated by 6% native PAGE as described in the
Reconstitution section above. For the first set of reactions with final volumes of 150 IJ,L. the 0.01

mM cisplatin reaction had an Rf = 0.081, and the 0.0025 m.M cisplatin reaction h~d an R f ;
0.020. For the reactions with final volumes of 90~, the 0.01 mM cisplatin reaction had an
0.070, and the 0.0025 mM cisplatin reaction had an R r

~

=

=0.017.
13

Generally two bands. both near the dye front, were observed: the band of higher mobility
representing the free 154-mer and the band of lower mobility representing the reconstituted,
nucJeosomal 154-mer. Both were excised and the DNA was eluted as described above.

Separation of Cross-linked DNA
Lyophilized, cisplatin-treated free and nucleosomal 154-mer samples were resuspended
in 10 J.LL of 5 M aqueous urea/0.1 % xylene cyanol and run on a 41 cm x 37 em, 0.35 m.m thick,
6% denaturing formamide/urea polyacrylamide gel [15 mL 40% 19: 1 acrylamide:bisacrylamide,
20 rnL 5X TBE, 30 m.L formamide, 42 g urea, 200 jlL 20% APS. 35 ilL of TEMED brought up
to a final volume of 100 rnL with H 20] at 55 watts at 3TC for -3 hr or until the dye had migrated

-10 cm from the bottom. For this procedure a Hoefer thermojacketed Poker Face gel stand was
used. A negative control containing unmodified DNA was also run on each gel.

Detenninarion of Cross-linking Pattern

If the above large gels were to be analyzed for cross-linking patterns, the gels were dried
under a vacuum for one hour with 20 minutes of heating at 55"C using a Drygel Sf. Model SE
1160 (Hoefer Scientific Instruments). The gels were then autoradiographed by placing them
under an intensifying screen and exposing them to film at -80°C.
Once a revealing autoracliograph was obtained, the gels were phosphorimaged using a
BioRad GS-505 Imaging System (Sample Exposure Platform, Screen Eraser and Molecular
Imager) with the software program Molecular Analyst version 2.1.2. Profiles were taken across
the cross-linking bands in order to determine the percentage of total cross-linking that each band
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represented. In addition, profiles were taken across the entire lane in order to determine the
percentage of total DNA that was interstrand cross-linked.

Mapping of Cisplatin Cross-linking Sites
In order to map the cross-linking sites, the large denaturing gel from above, while still on
the small glass plate, was autoractiographed. Based on the autoradiograph, sections revealing
cross-linking were excised from the gel, and DNA was eluted from these samples as described
above. Maxam-Gilbert G protection assays were then perfonned on the lyophilized, cross-linked
DNA samples in a manner similar to standard (Sambrook et ai.) 1989). A negative control
consisting of non cisplatin-reacted DNA was also subjected to the following G reaction and
piperictine cleavage. A 190

~L

portion of dimethyl sulfate (DMS) buffer [50 mM sodium

cacodylate (pH 7.0), 1 roM EDTA (pH 8.0)] was added to the dry pellet of DNA and the mixture
was chilled to O°e. A 5 ~ portion of 10% DMS was added, the cap was immediately closed,
and the contents were thoroughly mixed by vOI1exing for 10-15 seconds. The mixture was then
incubated at room temperature for 5 minutes. Next, 50 JlL of DMS stop solution [1.5 M sodium
acetate (pH 7.0), 1 M B-mercaptoethanol, 250

~g/mL

yeast tRNA] were added to each reaction

and the mixture was cooled to O°e. The samples were then ethanol precipitated in the following
manner. A 750 J..LL portion of chilled ethanol was added to each tube, and the tubes were
incubated at-20·C for at least 20 minutes and then centrifuged in an Eppendorf model 5402
refrigerated microceOlrifuge at 11,600 x g for 15 minutes at 4°C. The supernatants were removed
and discarded, and 300 ~L of 0.3 M NaOAc (pH 5) and 900 ~ of chilled ethano' were added to
each pellet. The tubes were incubated at -20"C for at leasl 20 minutes and then centrifuged as
previously described. The supernatants were removed and discarded and the pellets were washed
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in 1 rnL of chilled 80% ethanol. Washes also consisted of an incubation at -20°C for at least 20
minutes and centrifugation in the above manner. After the wash, the pellets were dried in the
Labconco Centrivap.
Cisplatin was then removed with the use of cyanide (Naser et aI., 1988). The lyophilized
pellets were resuspended in 100 !JL of 0.3 M NaCN (pH 8.0) and the mixture incubated at 37°C
for 3 hr. This reaction was ethanol precipitated as described in the sections above. The DNA was
then piperidine cleaved in the following manner. The lyophilized pellets were resuspended in
100 J..lL of 1 M piperidine. The mixtures were incubated at 90°C for 15 minutes, cooled to room
temperature, and dried in the Labconco Centrivap. To ensure the removal of all piperidine, the
pellets were resuspended in 40 ilL of H20, vonexed for 30 seconds, and dried in the centrivap.
This process was repeated once, and then 10 ilL of 5 M aqueous urea/D. 1% xylene cyanol were
added to each pellet. The tubes were vortexed in order to re-dissolve the DNA and briefly
centrifuged to deposit all of the fluid at the bonom of the tubes.
The samples were loaded onto a 41 cm x 37 cm, 0.35 mm thick, 6% denaturing
formamide/urea polyacrylamide gel [15 rnL 40% 19: 1 acrylamide:bisacrylamide, 20 mL 5X
TBE, 30 rnL formamide, 42 g urea, 200

~

20% APS, 35

~L

of TEMED brought up to a final

volume of 100 mL with H 20] and run at 5S watts at 3TC until the dye had migrated 10 cm from
the top. The sequencing gel was then dried, autoradiographed, and phosphorimaged as described
above.

ReconsriJucion Experiment
In order to assess the ability of cisplatin-treated DNA to be reconstituted with histones,

154-mer was isolated and radiolabeled as described above. The pellets of dried, isolated, free

16

154-mer were then reacted with cisplatin using reaction conditions and reconstitution conditions
similar to those described above. In this case, however, the reaction was scaled down to a 20 JAL
final volume. Again, two concentrations of cisplatin were used to cross-link DNA: 0.01 roM (R,

= 0.00271) and 0.0025 mM (R, = 0.000676). Because of the small final volume, an additional 1:5
dilution of the 0.1 roM cisplatin was made when setting up the 0.0025 roM cisplatin reactions.
Generally, there are histones present for the cisplatin reaction which tend to react with much of
the cisplatin by forming protein to DNA cross-links. Thus, in order to keep the true reaction ratio
of cisplatin to 154-mer, the 0.975 OD260 of histones were present for the cisplatin reaction part of
the experiment. See above for the rest of the required concentrations of constituents. At the end
of the 8 hr incubation at 37"C, 5 J..lL of 4 M NaCI were added, and the mixlUre was incubated at
4"C for I hr. From this point, the reconstitution was performed as above according to the Wolffe
method, slowly decreasing the salt concentration over time.
Next, a 6% native PAGE reconstitution gel was run as described above. The samples
consisted of 90

~

of these cisplatin-reacted, reconstituted samples and 10 ~ of dye. For

comparison, samples of the normal reconstituted, cisplarin reacted 154-mer at both
concentrations of cisplatin were also run. The gel was then autoradiographed as described above.

Transplarin Experimems
To detennine the cross-linking pattern of transplatin, 154-mer was isolated, radiolabeled,
and reconstituted as described above. Stock solutions, dilutions, and concentrations of transplatin
were identical ro those used in the cisplatin experiments described above. The reactants and final
volumes were also identical to those used in the above cisplatin experiments. The only difference
was that the transplatin reactions were incubated at 3TC for 2 weeks. A contra] reconstitution
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(volume 70

~L)

along with a control 0.01 mM cisplatin reaction were also incubated at 37°C for

2 weeks.
At the end of the two week period. 10

~

of dye was added to each of the samples and

the samples were run on a 6% native PAGE reconstitution gel as described above. Normal 8 hr
cisplatin reaction samples of both concentrations. along with a non-reacted reconstitution sample
were included on the gel for comparison. These cisplatin-reacted samples were prepared so that
the reactions would terminate at the exact end of the two week incubations. All samples.
cisplatin, traosplatin, and additionaJ controls were derived from the same two reconstitutions that
were stored at 4°C.
The gel was then aUloradiographed. and the bands were excised and treated as described
above. The cross-links were separated as described above and the gel was dried.
autoradiographed, and phosphorimaged as described above.
An experiment to determine the ability of transplatin-reacted DNA to reconstitute was
also performed. The conditions were exactly the same as those described above in the similar
cisplatin experiment, except that the transplatin reaction was incubated for 2 weeks. Similar
controls and gels were also run.
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RESULTS
The 32p_3' -end-labeled 154 bp EcoRlIRsa 1 restriction fragment of the 5S rRNA gene of

Xenopus borealis was incubated with purified chicken erythrocyte histones in order to
reconstitute the DNA. In order to obtain the best results for cross-linking experiments, both the
free and reconstituted nucleosomal DNA needed to be subjected to the same reaction conditions.
Thus, it was desirable to obtain a set of reconstitution parameters that yielded a 1: 1 ratio of
free:nucleosomaI154-mer. As described above, two methods of reconstitution, the Smerdon and
the Wolffe methods, were examined, and the amount of histones was varied. The preferred
method based on time required and simplicity of procedure was the Wolffe method. Thus,
initially only the Wolffe method was attempted, but these attempts failed because the 6% native
PAGE revealed that the samples were being lost during the procedure. At this point, the Smerdon
method was pursued, and a sample of I 54-mer, reconstituted with the maximal amount of
histones according to the Wolffe method, was included for comparison purposes only. However,
as can be seen in Figure 6, the sample reconstituted according to the Wolffe method yielded a
ratio of -3:7 for free:nucleosomal 154-mer. The Smerdon method, on the other hand, yielded
even higher proportions of nucleosomal 154-mer with ratios approaching 100% nucleosomal
154-mer.
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Smerdon
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Free DNA

Figure 6. Reconstitutioo experiment to determine a method that would yield a 1: 1
ratio of free:nuc\eosomal DNA. An autoradiograph of a 6% native PAGE to
separate free and nucleosomal DNA. The higher mobility band represents free
DNA and the lower mobility band is nucleosomal DNA. Lane 1: Wolffe
reconstitution with 0.975 OD 260 histones, 0.01 roM cisplatin; Lane 2: Wolffe
reconstitution with 0.975 OD 260 histones, 0.0025 mM cisplatin; Lane 3 and 4:
Smerdon reconstitution with 2.93 OD 260 histones, 0.01 mM cisplatin; Lane 5 and
6: Smerdon reconstitution with 2.93 OD 260 histones, 0.0025 mM cisplatin; Lane 7
and 10: Smerdon reconstitution with 4.88 ODu,o histones, 0.01 roM cisplatin;
Lane 8 and 9: Smerdon reconstitution with 4.88 OD260 histones, 0.0025 roM
cisplatin.
Because the Wolffe method seemed to work well, it was employed in all future experiments. The
Wolffe method was not further optimized, and all reconstitutions were done using 0.975 OD'260 of
histones, the maximal amount possible at this concentration of histones.
After successful reconstitution yielding a nearly 1: 1 ratio of free:nucleosomal 154-mer,
the mixture was then treated with two concentrations of cisplatin in an attempt to obtain
apprOXimately one cross-link per DNA molecule. Next, the free and nucleosomal 154-mer were
separated via 6% native PAGE, purified from the gel, and run on a 6% denaturing
formamide/urea PAGE gel to separate the cross-links. Autoradiographs indicated that the free
and nucleosomal 154-mer had similar cross-linking patterns (Figure 7).
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Figure 7. The interstrand cross-linking
pattern of both free and nucleosomal
DNA generated by cisplatin. An
autoradiograph of a fonnamideJurea
denaturing 6% PAGE gel to separate
cross-linking. All samples were
reconstituted according to the Wolffe
method using the maximal number of
histones (0.975 OD 260), except for the
sample in lane 5 which was
reconstituted according to the Smerdon
method. Lane 1: nucleosomal, 0.01 roM
cisplatin; Lane 2: free, 0.01 mM
cisplatin; Lane 3: nucleosomal, 0.0025
mM cisplatin; Lane 4: free, 0.0025 mM
cisplatin. Lane 5: nucleosomal, 0.01
roM cisplatin.
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Both concentrations of cisplatin also yielded similar patterns. The pattern of interstrand crosslinking consisted of what appear to be six or seven sets of bands, with the third set being the
most intense. A large native band was seen near the bottom of the gel along with a few bands of
"

higher mobility at low intensities. Furthermore, the negative control containing no cisplatin
yielded no low mobility bands (dat.a not shown), showing only the bottom band representing the
native unmodified DNA. Phosphorimagery of these gels and subsequent profile scanning of the
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interstrand cross-linked bands in each of the Janes to visualize the percentage of total of
interstrand cross-linking that each band represents gives the distribution in Figure 8.
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Figure 8. Two-dimensionaJ profile scans of the cisplatin interstrand cross-linked
DNA in the free and nucleosomal samples of the gel in Figure 7. The line with the
larger third peak corresponds [0 a scan of the interstrand cross-links in lane 3
(nucleosomal DNA) of [he gel in Figure 7. The other line corresponds to a scan of
the interstrand cross-links in lane 4 of the gel in Figure 7. The labeled peaks
represent major bands seen on the autoradiograph in Figure 7.
Profile scanning of each of the entire lanes to deterITl1ne the percentage of total DNA that was
interstrand cross-linked revealed that the highest percentage of interstrand cross-linked DNA in
any sample was 23% with the average no more than 15% (Table 1).
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Table 1: Total cisplatin interstrand .cross-linked DNA as a percentage of the total
DNA in free and nucleosomal samples. 2D profile scans were made of the entire
lane of each DNA sample from the phosphorimage of denaturing gels. The
percentages of interstrand cross-linking and percentages of native DNA were then
calculated from the counts calculated by the Molecular Analyst program. The
0.01 mM samples are an average of samples from 2 different gels. The native
DNA refers to non-cross linked DNA.
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In order to confirm the 5'GC sequence preference for interstrand cross-linking of DNA
by cisplatin on this particular 154-mer and with the hopes of determining which bands in the gel
of Figure 7 correspond to which sites, Maxam Gilbert G-protection assays were performed. After
the cross-links were separated using 6% denaturing PAGE, the gel was autoradiographed in an
attempt to determine where the interstrand cross-linking bands were in the gel so that they could
be separately excised. However, no such aucoradiograph has yet been obtained. Instead regions

were cut out where the interstrand cross-linked DNA was expected. The DNA was then
methylated by using dimethyl sulfate. Next, the cisplatin was removed using sodium cyanide,
and then the DNA was piperidine-cleaved into individual nucleOlides. Finally, the samples were
run on a 6% denaturing formamideJurea PAGE gel as described above, and the gel was
autoradiographed. Unfortunately, there are, as yet, no conclusive results. The loss of sample due
to the number of gels run and the decay of the radiolabel over time made analysj~ of the final gel

difficult because the signal was too faint even after two weeks in the -80°C freezer with an
intensifying screen.
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Because the pattern of cross-linking is the same in both free and nucleosomal DNA, we
have tried to circumvent this problem by only looking at the G-reaction results for free DNA. In
this procedure. the DNA was radiolabeled and the 154-mer isolated. The free DNA was then
reacted with cisplatin in a manner similar to the samples in the cisplatin-reacted-then
reconstituted experiment. Thus, the cisplatin was incubated with the same amount of histones
included in the original reconstitution reactions in order to try to ensure that conditions remain
similar to those in all previous experiments. After the 8 hr incubation period at 3TC. the DNA
was ethanol precipitated in an attempt to remove the histones. Next, cross-links were separated
using 6% denaturing formamide/urea PAGE, and the gels were then autoradiographed.
Unfortunately, the procedure has not gone further because the results of these autoradiographs
show the samples to be trapped in the wells. This is mostly likely due to ineffective removal of
histones. One possible solution to this problem would be a phenol:chloroform extraction prior to
ethanol precipitation, which is currently being tested.
A reconstitution experiment to determine whether cisplatin-reacted free DNA could be
reconstituted with histones was also performed. The cisplatin reaction was scaled down so that
the reconstitution volume and subsequent conditions would be similar. For the gel containing
both reconstituted and then reacted samples as well as reacted and then reconstituted samples see
Figure 9.
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Figure 9. Reconstitution experiment to determine whether cisplatin-reacted 154
mer could be incorporated into nucleosomal slrUcture. This is an autoradiograph
of a 6% native PAGE gel to separate nucleosomal and free DNA. Lanes 1-3 and
7-9 exhibit the normal 2 band, free and nucleosomal, distribution with the free
DNA represented by the higher mobility band and the nucleosomal DNA by the
lower mobility band. Lanes 1-3 and 7-9 contain samples that were first
reconstituted with histones and then reacted with cisplatin. Lanes 4 and 5 contain
samples that were first reacted with cisplatin and then reconstituted with histones.
Lanes 1 and 7: no cisplatin; Lane 2, 4, and 8: 0.01 roM cisplatin; Lanes 3, 5, and
9: 0.0025 mM cisplatin.
The samples that were reconstituted first and then reacted with cisplatin contain two distinct
lanes of free and nucieosomal DNA, while the reacted-then-reconstituted samples contain a
distribution of bands with both higher and lower mobility than the free and nucleosomal bands of
the controls.
At this point a few anempts have been made with the transplalin experiments. but few
significant results have been anained. The 154-mer was successfully radiolabeled, isolated and
reconstiruted. All samples were taken from two reconstitutions. The controls and reaction at 0.01
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mM were all taken from one reconstitution, and the reactions at 0.0025 mM were taken from the
second reconstitution. Reconstitutions were then incubated with tWO concentrations. 0.01 m.M
and 0.0025 mM, of transplatin for two weeks at 3TC. In addition. several controls were
incubated at 3TC for two weeks. One control consisted of reconstitution reacted with 0.01 mM
cisplatin. and another consisted of non-reacted reconstitution. At the end of the two week period,

a 6% native PAGE was performed on all samples including a portion of the reconstitution that
had been stored at 4°C, as well as control 8 hr reactions of cisplatin with reconstitution at both
the 0.01 mM and 0.0025 mM concentrations. The resulting autoradiograph of the gel is shown in

Figure 10.
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Figure 10. An autoradiograph of a 6% natlve PAGE to separate free and
nucleosomal DNA for the transpJatin experiments. Lanes 3-7 represent samples
that were first reconstituted and then reacted with cisplatin or transplatin. Lane 9
contains a sample that was first reacted with transplatin and then reconstituted.
All incubations were done at 37°C and all transplatin reactions were incubated for
a two week time period. Lane 1: non-reacted stored reconstitution; Lane 2: non
reacted reconstitution, incubated for 2 weeks; Lane 3: 0.01 roM cisplatin,
incubated for 2 weeks; Lane 4: 0.01 roM cisplatin, incubated for 8 hr; Lane 5:
0.0025 roM cisplatin, incubated for 8 hr; Lane 6: 0.01 roM transplatin; Lane 7:
0.0025 mM transplatin; Lane 9: 0.01 mM transplatin.

All of the samples that were incubated for two weeks seem to contain mainly free 154-mer,
while the control taken from the same reconstitution contains a more equal ponioo of
nucleosomal and free 154-mer. Thus, the nucleosomal DNA is somehow being converted back to
free DNA over lhe two week period at 3TC.
The experiment to test the abllity of lransplatln-reacted DNA

[0

reconstitute was

successful. The 154-mer was radiolabeled, isolated, and reacted with rransplatin at a
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concentration of 0.01 mM. The conditions of the transpJatin reaction were scaled down to have a
final volume of 20

~.

so that after the two week incubation period at 37°C, the DNA could be

reconstituted in a manner as similar as possible to previous reconstitution conditions. After
reconstitution, the free and nucleosomal DNA were then separated using 6% native PAGE. The
autoradiograph (Figure 10, Jane 9) shows a series of 4 bands, including bands representing the
normal free and reconstituted nucleosomal 154-mer. In addition to that, there seems

to

be some

dinucleosome fonning (lowest mObility) and a structure that migrates between the free and
nucleosomal.
No successful 6% denaturing PAGE have been run on transplatin-modified DNA at this
time.
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DISCUSSION
Cisplatin has been previously determined to interstrand cross-link duplex DNA at S'GC
sequences (Hopkins ef ai., 1991). For the purposes of this experiment we used the EcoRl/Rsa 1
154 bp restriction fragment of the 5S rRNA gene of Xenopus borealis. We attempted to establish
the interstrand cross-linking pattern of cisplatin for this fragment and to reconstitute the fragment
with histones isolated from chicken erythrocytes in order to determine whether nucleosomal
structure impacted the ability of cisplatin to interstrand cross-link DNA. Additional goals were to
confirm the 5'GC sequence preference of cisplacin within this DNA and to [est the ability of
cisplatin-reacted DNA to reconstitute with histones. We also attempted to look at differences in
interstrand cross-linking between cisplatin and its clinically inactive sterioisomer transplatin.
After successful 3' - end labeling and isolation of the 154-mer, a reconstitution procedure
was established. For the free vs. nucleosomal comparison studies of cisplatin cross-linking, a
reconstitution procedure that yielded a 1: 1 ratio of free to nucleosomal DNA was desired to
ensure that both types of DNA were subjected to the same reaction conditions. After
experimentation with two methods and a variety of histone concentrations, the Wolffe method of
reconstitution using maximal histone concentration was determined for use in all subsequent
experiments. These conditions yielded an approximately 3:7 ratio of free:nucleosomal 154-mer.
However, as time was shoft the procedure was not further optimized. Initial experiments with
this reconstitution method showed that the samples were being lost along the way, and the only
change in the procedure associated with a change in results was the switch from microcenrrifuge
tubes siliconized and sterilized in lab to commercially purchased sterilized, siliconized
microcentrifuge tubes. Thus, it seems as though our method of siliconization was not adequate
and resulted in loss of desired product.
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Previous studies indicated that reconstitution of the 154-mer with histones consistently
produces uniquely and precisely positioned core particles that place the fourteen potential sites of
cisplatin interstrand cross-linking in a variety of rotational and translational positions that could
make cross-linking in cenain positions by cisplatin quite difficult (Millard et al., 1998).
Autoradiography of reconstitution gels that separated free and nucleosomal DNA typically
revealed 2 bands: I of higher mobility representing the free DNA and one of lower mobility
representing the nucleosomal DNA (Figure 6 and 9). There were no additional bands present that
would represent dinucleosome formation or other undesirable arrangements of reconstituted
histones. indicating that the histones appear to be consistently reconstituting in the same manner.
Further confirmation of the nonnal precise positioning is, however. required in the form of a
hydroxyl radical cleavage study of the reconstituted 154-mer. Hydroxyl radical cleavage analysis
of this 154-mer complexed with histones from chicken erythrocytes has been performed in the
Millard lab before, yielding results that confirmed the precise rotational and translational
positioning of the core particle on this DNA fragment (Millard el ai., 1998). However, the
cleavage analysis has not been done on these particular samples of DNA and histones. The
additional study would, therefore, serve to confirm the consistency of the cleavage panern with
this panicular sample of DNA and histones.
Despite some uncertainty about the positioning of histones, once the reconstitution
procedure was established. reconstitutions were reacted with two concentrations of cisplarin, free
and nucleosomal 154-mer were separated, and the samples were subjected to denaturing PAGE
to separate the cross-links. Autoradiography revealed a consistent interstrand cross-linking
pattern of what look like 6 or 7 families of bands. identical in both free and nucleosomal154-mer
(Figure 7). In addition. very few inrrasrrand cross-links were visible in most samples. Intrastrand
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cross-links are represented by bands with lower mobility than native DNA. Although intrastrand
cross-links are the majority product of cross-links in vitro, it is not surprising that not many are
seen in these experiments because the conditions of the reaction have been adjusted to maximize
interstrand cross-linking. The consistency in pattern of cross-linking between nucleosomal and
free DNA, despite the difficulties in cross-linking that certain sites would seem likely to
experience based on the confonnation that the nucleosome imposes on the DNA, seems to poinr
to a locally dynamic model of the nucleosome.
Phosphorimagery and 2D profiling of each of the lanes of interstrand cross-Jinks
indicated that although there were no pattern differences between interslrand cross-linking of
free and nucleosomal 154-mer, there were some differences in intensity of interstrand cross
linking at particular sites (Figure 8). Profile scans of additional gels and concentrations yield
similar results to those seen in Figure 8 (data not shown). The size of the peak corresponding to
the third family of bands is much larger in the nucleosomal sample than in the free sample. Other
differences seem relatively minor including differences based on concentration of cisplatin.
However, it is interesting that the nucleosomal structure in the one case actually significantly
increases the ability of cisplatin to cross-link. Other cross-linkers that have been studied
including mitomycin C and the nitrogen mustards have been found to produce the same pattern
of cross-linking in nucleosomal DNA that they do in free DNA (Millard et al., 1998). When
differences in intensity of cross-linking at particular sites have been characterized, as in the case
of mitomycin C, the nucleosomal structure has been shown to inhibit the ability of the reagenllo
cross-link (Millard et al., 1998). This seems more likely as the nucleosome wol1ld seem to
impose some structural conformations on the DNA that would be quite unfavorable for reagents
to cross-link. For example, some of the conformations have both binding sites turned in towards
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the histones, seemingly making them unavailable for cross-linking. However. if the dynamic
model of nucleosomal structure is correct, then the nucleosomes could be transiently exposing
the DNA. thereby periodically providing access to regulatory proteins. Then, it does not seem
surprising that little differences due to nucleosomal structure is found.
A study that supports the dynamic theory of nucleosomaJ structure examined the
exchange of histones into replication inhibited DNA (Louters and Chalkley, 1985). This study
found that while quick exchanges occurred between newly synthesized HI. H2A. and H2B and
the histones previously present in the DNA, linle to no exchange of H3 and H4 in the core was
observed. These observations point to the conclusion that the core is able to bind and unbind the
DNA. allowing other molecules access to areas of the DNA that are unavailable in the coiled
structure.
2D profile scans of the phosphorimage were also done on each of the entire lanes in order
to determine the percent of total DNA that was incerstrand cross-linked. It was found that in all
samples less than 23% of the DNA was interstrand cross-linked, with the average percentage of
interstrand cross-linking being much lower (Table 1). These low percentages indicate that at
these cisplatin concentrations. we have single hit conditions in which there is no more than one
cisplatin binding per DNA molecule.

Cross~linking

percentages of up to 35% of the total DNA

are indicative of single hit conditions (Goodisman and Dabrowiak. 1985). Thus, both
concentrations of cisplatin seem to be optimal for interstrand cross-linking investigation.
The third band that exhibits the major difference in efficiency of interstrand cross-linking
between the free and nucleosomal samples is believed to correspond to a site that is three helical
turns from the dyad. This prediction is based on a former hydroxyl radical cleavage study of
reconstituted S5 rRNA gene of Xenopus borealis (Kuduvalli et ai., 1995). In the table below the
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sites that have potential for interstrand cross-linking are listed along with their translational and
rotational positioning (Table 2).
Table 2: The predicted migratory pattern of cisplatin interstrand cross-linked sites
in the 154 bp EcoRl/Rsal restriction fragment of the 5S rRNA gene of Xenopus
borealis. The table contains a list of sites that could potentially be interstrand
cross-linked by cisplatin, along with their translational and rotational positioning.
The translational positioning refers to·the number of base pairs that a site is from
the dyad. site C76 for this sequence. The rotational positioning refers to the
orientation of the site with respect to the histone core particle (i.e. facing toward
or away from the histone molecules). The migratory pattern was predicted using
the information that the closer a site is to the dyad, the less mobile it will be when
interstrand cross-linked. Resolution of the denaturing gel was also taken into
account when making the predictions. The bands are given in order of least
mobile (1) to most mobile (6).

Cross-lillkifig .' -'Translatlonaf----' 'Rotafiona'--~'='-::~~Predicted~'~~
Positioning
Site
- .
- ...... ~€!~~n~~~~~_Mjgrd~~J
-"
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GI2
G25
G30
G44
G47
G68
G75
G79
G86
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~
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64
51
46

32
29
8
1

3
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29
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away
neither
neither
away
facing
facing
away
facing
away
away
facing
away
away

5
4
4

3

3

2
I

I

2
3
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It has been previously shown that the closer a site is to the dyad. the less mobile it wiU be on a

gel when it has been interstrand cross-linked (Millard et al., 1991). We used this piece of
information. keeping in mind the resolution of the denaturing gels,

to

make precfictions about the

migratory panern that would be seen on a gel. Of course, later on these predictions will have to
be substantiated by Maxam Gilbert G protections assay results of these samples. In this
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prediction, the third band would correspond to cross-linking at sites G44, G47, and G 105.
Assuming that there are 10-11 base pairs per helical rum, the site would be approximately three
helical turns from the dyad (located at site C76). Of interest is thal, at approximately three helical
turns upstream from the dyad, histone H4 interacts with the DNA (Pruss and Wolffe, 1993).
Perhaps the increase in intensity of cross-linking seen near these sites in nucleosomal DNA is
thus due to structural influences of the histone H4 protein.
The reconstitution experiment to determine whether cisplatin- and transplatin-reacted
DNA could be reconstituted seems to indicate that the nucleosome as a whole is not a dynamic
structure even though it may be locally dynamic. As described earlier in this experiment the
cisplatin and transplatin reactions were scaled down and then subjected to conditions quite
similar to the previous reconstitutions. When 6% native PAGE was performed on these samples
to separate nucleosomal and free DNA, the autoradiographs revealed many additional bands at a
variety of molecular weights instead of the normal two band, reconstituted and free, distribution
(Figures 9 and 10). This suggests that the cross-l inking distorts the structure of the 154-mer to
the point where the nucleosome no longer has a single defined translational and rotational
positioning. The molecule is too distorted in order to accept the regular histone configuration. A
variety of structures can, therefore, be formed with the histones conglomerating onto the DNA in
order to accommodate the bends. Thus, the nucleosome does not seem to be quite as flexible in
accommodating distorted structures when the nucleosome is not at first present.
Unfortunately, the experiments with transplatin have not yet been completed due to some
difficulties with the procedure. As reponed in the results, the two week incubation period at 3TC
required for optimal interstrand cross-linking somehow, in a manner unrelated to the cross
linker, convens most of the nucleosomal DNA back to free DNA (Figure 10). During the
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incubation period, all of the solution in the tube evaporates and re-condenses at the top of the
microcentrifuge tube. Some of the solution is probably left in vapor form, thus decreasing the
volume of the solution at the top of the tube, and thereby increasing the salt concentration. This
change in salt concentration could be drastic enough to disrupt the histones. Spinning the tubes
down everyday might be the solution to this problem.
In conclusion, we have found that nucleosomal structure is a rather minor inhibitor of
cisplatin interstrand cross-linking reactions with DNA. These data, therefore, support a locally
dynamic model of nucleosornal structure. Future studies should, however, include a hydroxyl
radical cleavage analysis to confirm precise positioning of the nucleosorne. In addilion. studies
with transplatin, the clinically inactive stereoisomer of cisplatin, in comparison could provide
some further insight into cross-linking and its role in relation to antitumor activity.
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